Jang S, Choi J, Oh J, Yeom J, Hong N, Lee N
Front Psychiatry. 2021; 11:564618.
PMID: 33551860
PMC: 7859615.
DOI: 10.3389/fpsyt.2020.564618.
Kobayashi M, Ikeda T, Tokuda T, Monden Y, Nagashima M, Mizushima S
Neurophotonics. 2020; 7(2):025003.
PMID: 32377545
PMC: 7201297.
DOI: 10.1117/1.NPh.7.2.025003.
van den Boom B, Mooij A, Miseviciute I, Denys D, Willuhn I
Genes Brain Behav. 2019; 18(4):e12557.
PMID: 30688005
PMC: 6487954.
DOI: 10.1111/gbb.12557.
Brahmbhatt K, Hilty D, Hah M, Han J, Angkustsiri K, Schweitzer J
J Adolesc Health. 2016; 59(2):135-43.
PMID: 27209327
PMC: 5576000.
DOI: 10.1016/j.jadohealth.2016.03.025.
Powell S, Frydenberg M, Thomsen P
Child Adolesc Psychiatry Ment Health. 2015; 9:50.
PMID: 26516345
PMC: 4624592.
DOI: 10.1186/s13034-015-0082-3.
Neuropharmacological effect of methylphenidate on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopy.
Nagashima M, Monden Y, Dan I, Dan H, Tsuzuki D, Mizutani T
Neurophotonics. 2015; 1(1):015001.
PMID: 26157971
PMC: 4478959.
DOI: 10.1117/1.NPh.1.1.015001.
Overexpression of the type 1 adenylyl cyclase in the forebrain leads to deficits of behavioral inhibition.
Chen X, Cao H, Saraf A, Zweifel L, Storm D
J Neurosci. 2015; 35(1):339-51.
PMID: 25568126
PMC: 4287152.
DOI: 10.1523/JNEUROSCI.2478-14.2015.
Right prefrontal activation as a neuro-functional biomarker for monitoring acute effects of methylphenidate in ADHD children: An fNIRS study.
Monden Y, Dan H, Nagashima M, Dan I, Tsuzuki D, Kyutoku Y
Neuroimage Clin. 2013; 1(1):131-40.
PMID: 24179746
PMC: 3757725.
DOI: 10.1016/j.nicl.2012.10.001.
Objective Measures of Behavior Manifestations in Adult ADHD and Differentiation from Participants with Bipolar II Disorder, Borderline Personality Disorder, Participants with Disconfirmed ADHD as Well as Normative Participants.
Edebol H, Helldin L, Norlander T
Clin Pract Epidemiol Ment Health. 2012; 8:134-43.
PMID: 23166565
PMC: 3497060.
DOI: 10.2174/1745017901208010134.
Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate.
Bruxel E, Salatino-Oliveira A, Genro J, Zeni C, Polanczyk G, Chazan R
Pharmacogenomics J. 2012; 13(5):476-80.
PMID: 22688218
DOI: 10.1038/tpj.2012.25.
Role of zinc in the pathogenesis of attention-deficit hyperactivity disorder: implications for research and treatment.
Lepping P, Huber M
CNS Drugs. 2010; 24(9):721-8.
PMID: 20806985
DOI: 10.2165/11537610-000000000-00000.
A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD.
Wilens T, Klint T, Adler L, West S, Wesnes K, Graff O
Behav Brain Funct. 2008; 4:24.
PMID: 18554401
PMC: 2442604.
DOI: 10.1186/1744-9081-4-24.
Drug use related problems among nonmedical users of prescription stimulants: a web-based survey of college students from a Midwestern university.
McCabe S, Teter C
Drug Alcohol Depend. 2007; 91(1):69-76.
PMID: 17624690
PMC: 2637564.
DOI: 10.1016/j.drugalcdep.2007.05.010.
The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder.
Faraone S
Eur Child Adolesc Psychiatry. 2005; 14(1):1-10.
PMID: 15756510
DOI: 10.1007/s00787-005-0429-z.